Pulmonary hypertension is also known as high blood pressure. It can be aterial, hypoxic, venous, thromboembolic, or miscellaneous, and medicines which treat any of them are collectively known as agents for pulmonary hypertension.
Recommended Resources
Novel Agents for the Treatment of Pulmonary Arterial Hypertension
Outlines the use of these agents in patients with PAH, prostanoids, endothelin antagonists, and future directions.
http://www.touchrespiratory.com/articles/novel-agents-treatment-pulmonary-arterial-hypertension
Website provides support information for PAH patients and their caregivers.
http://www.pahpathways.com/
Primary Pulmonary Hypertension and Responsiveness to Vasodilator Agents
Details the use of pharmacological agents for the treatment of pulmonary hypertension, clinical information, and a list of other articles which cite this paper.
http://www.circ.ahajournals.org/cgi/content/abstract/80/5/1207
Pfizer's site about dildenafil citrate, brand name Revatio, for patients, caregivers, and health care professionals includes safety information, an explanation of how it works, and details about PAH.
http://www.revatio.com/
Available from Actelion Pharmaceuticals US, Veletri is a prescription medication that is given intravenously for the treatment of adults with certain types of severe pulmonary arterial hypertension (PAH), a condition in which the blood pressure is too high in the blood vessels between the heart and the lungs. Veletric can improve the ability to exercise as measured by how far the patient can walk in six minutes. Safety information and general information about the drug are provided.
https://www.veletri.com/
